Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$4,166.59
+252.93% vs spot
Strong Buy
Spot price
$1,180.58
Mkt cap $23.86B
subtle cardAnalyst PT consensus
$1,490.83
+26.28% vs spot
subtle cardMethods covered
13 / 15
11 in blend
subtle cardFootball field
MTD · fair-value range by method
Method comparison
MTD · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| DCF · FCFF | dcf | $12,165.19 | $3,050.75 – $11,809.04 | +930.44% | 30.1% | WACC 2.4%, g₀=7.6%, gₗ=2.0% | high |
| DCF · FCFE | dcf | $558.00 | $441.06 – $718.88 | -52.74% | 22.6% | kₑ 10.3%, g₀=7.6%, gₗ=2.0% | high |
| Justified P/E | multiple | $0.00 | $0.00 – $0.00 | -100.00% | — | Fair P/E 0.0 (payout 0%, kₑ 10.3%, g 7.6%) | low |
| P/E · sector | multiple | $927.74 | $816.41 – $1,039.07 | -21.42% | 18.0% | EPS 42.17 × peer P/E 22.0 | med |
| P/S · sector | multiple | $738.30 | $627.56 – $849.05 | -37.46% | 4.5% | Rev/sh 184.58 × peer P/S 4.00 | med |
| EV / EBITDA | multiple | $744.67 | $655.31 – $834.03 | -36.92% | 15.0% | EBITDA × peer 15.0× − ND 2.3B | high |
| EV / EBIT | multiple | $818.56 | $695.78 – $941.34 | -30.66% | 3.0% | EBIT × peer 18.0× − ND | med |
| EV / Sales | multiple | $523.20 | $444.72 – $601.68 | -55.68% | 3.0% | Sales × peer 3.40× − ND | med |
| PEG-anchored | multiple | $446.73 | $379.72 – $513.75 | -62.16% | 1.5% | PEG=1, fwd EPS g 10.6% | med |
| Earnings power | intrinsic | $1,649.30 | $1,451.38 – $1,847.21 | +39.70% | 0.8% | NOPAT / WACC, no growth | med |
| Graham revised | intrinsic | $988.58 | $840.29 – $1,136.87 | -16.26% | 0.8% | EPS×(8.5+2g)·4.4/Y | low |
| Lynch P/E=g | intrinsic | $321.81 | $273.54 – $370.08 | -72.74% | 0.8% | PE = g (7.6) | low |
| Book NAV | asset | -$1.08 | -$1.03 – -$1.14 | -100.09% | — | (Assets − Liabilities) / Shares | high |
| Liquidation | asset | — | — | — | — | Cash 100% + non-cash 70% − Liab. | low |
| Reverse DCF | reverse | — | — | — | — | Implied g -20.0% · Pessimistic — market pricing decline | high |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (1.31)β | × 1.31 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 10.31% |
| Pre-tax cost of debtkd | 2.92% |
| Effective tax ratet | 17.1% |
| After-tax cost of debt | 2.42% |
| Equity weight$-0.0B | -1.0% |
| Debt weight$2.3B | 101.0% |
| WACC | 2.42% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | 5.36% |
| Analyst forward EPS growthFMP | 10.59% |
| Historical 5y revenue CAGRFY | 2.01% |
| Historical 5y EPS CAGRFY | 6.50% |
| Sustainable g (ROE × retention)Δ | — |
| Blended near-term growth (g₀) | 7.63% |
| Terminal growth (gₗ) | 2.00% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2023-12-31)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Healthcare (live sector PE unavailable)
- FMP /price-target-consensus— mean $1,490.83
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.